Samit Verma appointed as CEO of NeuroEquilibrium

Prior to joining NeuroEquilibrium, Samit held the position of Managing Director at Amplifon India

NeuroEquilibrium has announced the appointment of seasoned industry veteran Samit Verma as the Chief Executive Officer.

Prior to joining NeuroEquilibrium, Samit held the position of Managing Director at Amplifon India, a subsidiary of Amplifon S.p.A, a renowned Italian multinational corporation and a global frontrunner in the hearing care industry across 29 countries.

During his 12-year journey at Amplifon, Samit played a pivotal role in establishing the business from the ground up, growing it to encompass more than 250 point-of-sales.

Commenting on the latest development, NeuroEquilibrium Founder Rajneesh Bhandari said, “NeuroEquilibrium is going through a fascinating phase of growth both in the domestic market and expanding our global presence, given the vast traction and demand and support from our marquee investors Kotak Ventures, Unicorn India Ventures, and RVCF ventures. We and our investors are delighted to welcome Samit Verma to the NeuroEquilibrium family”.

“Samit comes with a wealth of experience and, most importantly, resonates strongly with our values and ethics in our drive for clinical and technological excellence. Under his able and forward-looking leadership, we are confident that we will scale new heights and build NeuroEquilibrium into a truly global organisation with our continued focus on delivering best-in-class clinical excellence for our patients and partners combined with our deep-tech proprietary platform power by AI,” said Dr Anita Bhandari, a renowned neurotologist and co-founder NeuroEquilibrium.

“I’m thrilled to take on the role of CEO at NeuroEquilibrium, a cutting-edge medical technology startup. It’s exciting to lead the world’s largest network of clinics focused on Dizziness, Vertigo, and Balance disorders. I look forward to using my experience to contribute to NeuroEquilibrium’s growth and commitment to providing excellent clinical care”, Samit Verma, CEO, NeuroEquilibrium.